Company intelligence / Profile preview

Daesang

Ownership: Private
Employees: ~3916
Development stage: Other

Overview

Daesang is a global leader in fermentation technology producing amino acids such as L-glutamine, L-histidine, L-arginine, and L-lysine for the food industry, animal feed sector, dietary supplements market, and pharmaceutical ingredient supply. The company's focus is on high-value-added functional ingredients through advanced bioengineering but does not have clinical trial results typical of drug development companies.

Modalities: Amino acids
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Daesang.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daesang.

Explore the full profile